These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 33729209)

  • 21. Is there a rational basis for cannabinoids research and development in ocular pain therapy? A systematic review of preclinical evidence.
    Scuteri D; Rombolà L; Hamamura K; Sakurada T; Watanabe C; Sakurada S; Guida F; Boccella S; Maione S; Gallo Afflitto G; Nucci C; Tonin P; Bagetta G; Corasaniti MT
    Biomed Pharmacother; 2022 Feb; 146():112505. PubMed ID: 34891121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Efficacy, tolerability and safety of cannabinoids for chronic neuropathic pain: A systematic review of randomized controlled studies].
    Petzke F; Enax-Krumova EK; Häuser W
    Schmerz; 2016 Feb; 30(1):62-88. PubMed ID: 26830780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Endocannabinoid System Modulating Levels of Consciousness, Emotions and Likely Dream Contents.
    Murillo-Rodriguez E; Pastrana-Trejo JC; Salas-Crisóstomo M; de-la-Cruz M
    CNS Neurol Disord Drug Targets; 2017; 16(4):370-379. PubMed ID: 28240187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cannabinoids, cannabis, and cannabis-based medicines for pain management: an overview of systematic reviews.
    Moore RA; Fisher E; Finn DP; Finnerup NB; Gilron I; Haroutounian S; Krane E; Rice ASC; Rowbotham M; Wallace M; Eccleston C
    Pain; 2021 Jul; 162(Suppl 1):S67-S79. PubMed ID: 32804833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cannabinoid analgesia as a potential new therapeutic option in the treatment of chronic pain.
    Burns TL; Ineck JR
    Ann Pharmacother; 2006 Feb; 40(2):251-60. PubMed ID: 16449552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic potential of cannabinoids in CNS disease.
    Croxford JL
    CNS Drugs; 2003; 17(3):179-202. PubMed ID: 12617697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brain permeant and impermeant inhibitors of fatty-acid amide hydrolase suppress the development and maintenance of paclitaxel-induced neuropathic pain without producing tolerance or physical dependence in vivo and synergize with paclitaxel to reduce tumor cell line viability in vitro.
    Slivicki RA; Xu Z; Mali SS; Hohmann AG
    Pharmacol Res; 2019 Apr; 142():267-282. PubMed ID: 30739035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cannabinoids and the expanded endocannabinoid system in neurological disorders.
    Cristino L; Bisogno T; Di Marzo V
    Nat Rev Neurol; 2020 Jan; 16(1):9-29. PubMed ID: 31831863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of cannabinoids in the management of neuropathic pain.
    Martín Fontelles MI; Goicoechea García C
    CNS Drugs; 2008; 22(8):645-53. PubMed ID: 18601303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cannabinoids and Pain: Sites and Mechanisms of Action.
    Starowicz K; Finn DP
    Adv Pharmacol; 2017; 80():437-475. PubMed ID: 28826543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cannabis-based medicines and pain: a review of potential synergistic and entourage effects.
    Anand U; Pacchetti B; Anand P; Sodergren MH
    Pain Manag; 2021 Apr; 11(4):395-403. PubMed ID: 33703917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cannabinoids and the endocannabinoid system in fibromyalgia: A review of preclinical and clinical research.
    Bourke SL; Schlag AK; O'Sullivan SE; Nutt DJ; Finn DP
    Pharmacol Ther; 2022 Dec; 240():108216. PubMed ID: 35609718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoacylglycerol Lipase Protects the Presynaptic Cannabinoid 1 Receptor from Desensitization by Endocannabinoids after Persistent Inflammation.
    Bouchet CA; McPherson KB; Coutens B; Janowsky A; Ingram SL
    J Neurosci; 2023 Jul; 43(30):5458-5467. PubMed ID: 37414560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emerging role of cannabinoids and synthetic cannabinoid receptor 1/cannabinoid receptor 2 receptor agonists in cancer treatment and chemotherapy-associated cancer management.
    Shah SA; Gupta AS; Kumar P
    J Cancer Res Ther; 2021; 17(1):1-9. PubMed ID: 33723124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medical Use of Cannabinoids.
    Fraguas-Sánchez AI; Torres-Suárez AI
    Drugs; 2018 Nov; 78(16):1665-1703. PubMed ID: 30374797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [News about therapeutic use of Cannabis and endocannabinoid system].
    Duran M; Laporte JR; Capellà D
    Med Clin (Barc); 2004 Mar; 122(10):390-8. PubMed ID: 15033046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands.
    Davis MP
    Expert Opin Investig Drugs; 2014 Aug; 23(8):1123-40. PubMed ID: 24836296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cannabinoids and cancer pain: A new hope or a false dawn?
    Brown MRD; Farquhar-Smith WP
    Eur J Intern Med; 2018 Mar; 49():30-36. PubMed ID: 29482740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy, tolerability and safety of cannabis-based medicines for chronic pain management - An overview of systematic reviews.
    Häuser W; Petzke F; Fitzcharles MA
    Eur J Pain; 2018 Mar; 22(3):455-470. PubMed ID: 29034533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cannabinoids, cannabis, and cannabis-based medicine for pain management: a systematic review of randomised controlled trials.
    Fisher E; Moore RA; Fogarty AE; Finn DP; Finnerup NB; Gilron I; Haroutounian S; Krane E; Rice ASC; Rowbotham M; Wallace M; Eccleston C
    Pain; 2021 Jul; 162(Suppl 1):S45-S66. PubMed ID: 32804836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.